8 Red Days In A Row: Veeva Systems Stock Is Down 14%
Today’s big story: Will 2027 Be A 2022 Repeat For Stocks?
Veeva Systems (VEEV) stock has fallen for 8 consecutive trading days, losing 14.2% over that stretch. That erased about $7.1 billion from the company’s market value, which now stands at about $42.7 billion. The stock closed at $262.92 on Thursday, November 19, 18.6% below its 52-week high of $323.04 and 73.6% above its low of $151.43.

The Streak Next To The S&P 500
Returns for VEEV and the S&P 500 over the streak and the periods around it, all ending Thursday, November 19 and including dividends:
| Return Period | VEEV | S&P 500 |
|---|---|---|
| 1 Day | -5.2% | -2.0% |
| 8 Days (Current Streak) | -14.2% | -4.9% |
| 1 Month (21 Trading Days) | -18.0% | -7.4% |
| 3 Months (63 Trading Days) | 6.1% | -6.2% |
| Year To Date | 17.8% | 5.9% |
| 1 Year (252 Trading Days) | -3.9% | 9.7% |
A Stock-Specific Slide, Or A Market Move?
Over the same 8 trading days, the S&P 500 returned -4.9% including dividends, so the slide is mostly Veeva Systems’ own story rather than the market’s. 2 other S&P 500 stocks are currently on losing streaks of 8 days or longer. Over the past three months the stock is up 6.1%, a window that includes the streak; over the other 55 sessions of that window it was up 23.6%.
What The Numbers Say About The Slide
On the fundamentals, revenue grew 16.5% over the last twelve months, against a median of 7.9% for S&P 500 Health Care stocks; its operating margin is 29.9%, versus a median of 17.4%; and the stock trades at 42.1 times trailing earnings against a median of 30.2. The read is mixed.
If the drop has you weighing an entry, resist buying on price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still hold up.
For anyone who would rather back the theme than one company, a U.S. healthcare providers ETF like IHF holds the whole group, not just this stock. It is still a concentrated bet on one theme, which is the gap the portfolio below is built to close.
A Slide Like This Is Why Diversification Exists
Watching one stock fall day after day is the clearest lesson the market teaches about single-name risk. Whether this particular decline is an opportunity or a warning, the deeper point is the same: no one name should be able to do this to your portfolio.
The Trefis High Quality (HQ) Portfolio is built on that principle: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Study the slide; spread the risk.